logo

Last Update

This profile was last updated on 8/11/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Douglas Bibus?

Douglas M. Bibus

President

Lipid Technologies LLC

HQ Phone:  (507) 437-6483

Direct Phone: (507) ***-****direct phone

Email: d***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Web References(87 Total References)


AOCS Foundation - Leadership

www.aocsfoundation.org [cached]

Doug Bibus
Doug Bibus Foundation Board Treasurer Lipid Technologies, LLC


Governance

www.aocs.org [cached]

Treasurer, Doug Bibus, Lipid Technologies, LLC, Minnesota, USA


Company Profile | Lipid Technologies

lipidlab.com [cached]

Douglas M Bibus, MS, PhD
President Dr. Doug Bibus founded Lipid Technologies in the 1995, a spin off from his academic laboratory at the University of Minnesota. Dr Bibus is also a community faculty member at The Center for Spirituality and Healing at the University of Minnesota and a researcher in the area of fatty acid biochemistry and nutrition. Dr. Bibus is considered an expert in the area of omega 3 fatty acids and their analysis that stems from his time in the academic lab of Dr Ralph T. Holman who invented the term 'omega 3', discovered the metabolism and definitive essentiality nature of omega 3. Doug directs Lipid Technologies, LLC., an analytical and consulting group that focuses on fatty acid and lipid analysis and integration of lipid nutrition in biotech and food applications. His research interests include the role of essential fatty acids in human and animal nutrition, the role of omega 3 fatty acids in the down regulation of the inflammatory response and the application of fatty acids in the treatment of disease. Other ongoing research has or is examining the role of omega 3 and fatty acid nutrition and its implications in the treatment of depression, schizophrenia, Tourette's syndrome, cystic fibrosis, Crohn's disease, heart disease, arthritis, critically injured and adult respiratory distress patients and in patients with autoimmune disorders. Dr. Bibus is a member of several organizations including the American Oil Chemists' Society, the American Chemical Society, the Society for Critical Care Medicine and the International Society for the Study of Fatty Acids and Lipids. He has been the recipient of the American Oil Chemists' Honored Student Award and a two-time winner of the American Chemical Society's Award in Analytical Chemistry. Doug is also a board member for the American Oil Chemists' Society. doug-bibus Douglas M Bibus, MS, PhD President Dr. Doug Bibus founded Lipid Technologies in the 1995, a spin off from his academic laboratory at the University of Minnesota. Dr Bibus is also a community faculty member at The Center for Spirituality and Healing at the University of Minnesota and a researcher in the area of fatty acid biochemistry and nutrition. Dr. Bibus is considered an expert in the area of omega 3 fatty acids and their analysis that stems from his time in the academic lab of Dr Ralph T. Holman who invented the term 'omega 3', discovered the metabolism and definitive essentiality nature of omega 3. Doug directs Lipid Technologies, LLC., an analytical and consulting group that focuses on fatty acid and lipid analysis and integration of lipid nutrition in biotech and food applications. His research interests include the role of essential fatty acids in human and animal nutrition, the role of omega 3 fatty acids in the down regulation of the inflammatory response and the application of fatty acids in the treatment of disease. Other ongoing research has or is examining the role of omega 3 and fatty acid nutrition and its implications in the treatment of depression, schizophrenia, Tourette's syndrome, cystic fibrosis, Crohn's disease, heart disease, arthritis, critically injured and adult respiratory distress patients and in patients with autoimmune disorders. Dr. Bibus is a member of several organizations including the American Oil Chemists' Society, the American Chemical Society, the Society for Critical Care Medicine and the International Society for the Study of Fatty Acids and Lipids. He has been the recipient of the American Oil Chemists' Honored Student Award and a two-time winner of the American Chemical Society's Award in Analytical Chemistry. Doug is also a board member for the American Oil Chemists' Society.


Dr. Douglas M. Bibus | Center for Applied Health Sciences

www.appliedhealthsciences.org [cached]

Dr. Douglas M. Bibus
Dr. Doug Bibus is community faculty member at The Center for Spirituality and Healing at the University of Minnesota and a researcher in the area of fatty acid biochemistry and nutrition. Dr. Bibus is considered one of the top omega 3 experts in the world and stems from the academic lab of Dr Ralph T. Holman who invented the term 'omega 3', discovered the metabolism and definitive essentiality nature of omega 3. In addition to his work with the Center, Doug directs Lipid Technologies, LLC., an analytical and consulting group that focuses on fatty acid and lipid analysis and integration of lipid nutrition in biotech and food applications. His research interests include the role of essential fatty acids in human and animal nutrition, the role of omega 3 fatty acids in the down regulation of the inflammatory response and the application of fatty acids in the treatment of disease. Other ongoing research has or is examining the role of omega 3 and fatty acid nutrition and its implications in the treatment of depression, schizophrenia, Tourette's syndrome, cystic fibrosis, Crohn's disease, heart disease, arthritis, critically injured and adult respiratory distress patients and in patients with autoimmune disorders. Dr. Bibus has also recently developed an Omega 3 blood test (www.Omega3Test.com) to identify levels of omega 3 in the blood. Dr. Bibus is a member of several organizations including the American Oil Chemists' Society, the American Chemical Society, the Society for Critical Care Medicine and the International Society for the Study of Fatty Acids and Lipids. He has been the recipient of the American Oil Chemists' Honored Student Award and a two-time winner of the American Chemical Society's Award in Analytical Chemistry. Doug is also a board member for the American Oil Chemists' Society and also serves on that society's Foundation board. In addition to presenting at numerous professional meetings, Dr. Bibus is a sought after lecturer and author in the area of human and animal health. Dr. Douglas M. Bibus


News Center | Bioriginal

www.bioriginal.com [cached]

The study, "United States menhaden oil could save billions in U.S. health care costs and improve IQ in children," is authored by Dr. Doug Bibus, President of Lipid Technologies and an expert on omega-3 fatty acids.
"Menhaden oil offers a rich and sustainable source of EPA, DPA and DHA, the long chain omega-3 fatty acids that are required for proper health and development," said Dr. Bibus. Dr. Bibus' paper and states that adhering to these guidelines could result in a net increase of IQ by 5.5 points in developing children and could improve early verbal development. Dr. Bibus' study finds that the U.S. supply of menhaden oil is also able to meet these needs. The amount of menhaden oil used to fuel aquaculture is enough "to supply every pregnant and lactating woman in the U.S. with two to three servings of oily fish per week." "The deficiency of omega-3 fatty acids is wide spread and completely preventable," said Dr. Bibus.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory